Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions: CETP has no preference for cholesteryl esters in HDL versus LDL
- PMID: 10073979
- DOI: 10.1161/01.atv.19.3.718
Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions: CETP has no preference for cholesteryl esters in HDL versus LDL
Abstract
Cholesteryl ester transfer protein (CETP) catalyzes the net transfer of cholesteryl ester (CE) between lipoproteins in exchange for triglyceride (heteroexchange). It is generally held that CETP primarily associates with HDL and preferentially transfers lipids from this lipoprotein fraction. This is illustrated in normal plasma where HDL is the primary donor of the CE transferred to VLDL by CETP. However, in plasma deficient in lipid transfer inhibitor protein (LTIP) activity, HDL and LDL are equivalent donors of CE to VLDL (Arterioscler Thromb Vasc Biol. 1997;17:1716-1724). Thus, we have hypothesized that the preferential transfer of CE from HDL in normal plasma is a consequence of LTIP activity and not caused by a preferential CETP-HDL interaction. We have tested this hypothesis in lipid mass transfer assays with partially purified CETP and LTIP, and isolated lipoproteins. With a physiological mixture of lipoproteins, the preference ratio (PR, ratio of CE mass transferred from a lipoprotein to VLDL versus its CE content) for HDL and LDL in the presence of CETP alone was approximately 1 (ie, no preference). Fourfold variations in the LDL/HDL ratio or in the levels of HDL in the assay did not result in significant preferential transfer from any lipoprotein. On addition of LTIP, the PR for HDL was increased up to 2-fold and that for LDL decreased in a concentration-dependent manner. Under all conditions where LDL and HDL levels were varied, LTIP consistently resulted in a PR >1 for CE transfer from HDL. Short-term experiments with radiolabeled lipoproteins and either partially purified or homogenous CETP confirmed these observations and further demonstrated that CETP has a strong predilection to mediate homoexchange (bidirectional transfer of the same lipid) rather than heteroexchange (CE for TG); LTIP had no effect on the selection of CE or TG by CETP or its mechanism of action. We conclude, in contrast to current opinion, that CETP has no preference for CE in HDL versus LDL, suggesting that the previously reported stable binding of CETP to HDL does not result in selective transfer from this lipoprotein. These data suggest that LTIP is responsible for the preferential transfer of CE from HDL that occurs in plasma. CETP and LTIP cooperatively determine the extent of CETP-mediated remodeling of individual lipoprotein fractions.
Similar articles
-
Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP).J Biol Chem. 2003 Oct 17;278(42):40859-66. doi: 10.1074/jbc.M306580200. Epub 2003 Aug 7. J Biol Chem. 2003. PMID: 12907677
-
Suppression of lipid transfer inhibitor protein activity by oleate. A novel mechanism of cholesteryl ester transfer protein regulation by plasma free fatty acids.Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3041-8. doi: 10.1161/01.atv.17.11.3041. Arterioscler Thromb Vasc Biol. 1997. PMID: 9409291
-
Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemia.Eur J Clin Invest. 1996 Jun;26(6):485-94. doi: 10.1046/j.1365-2362.1996.168318.x. Eur J Clin Invest. 1996. PMID: 8817163
-
Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia.Pharmacol Ther. 2004 Jan;101(1):17-38. doi: 10.1016/j.pharmthera.2003.10.001. Pharmacol Ther. 2004. PMID: 14729390 Review.
-
Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia.Mol Neurodegener. 2023 Nov 16;18(1):86. doi: 10.1186/s13024-023-00671-y. Mol Neurodegener. 2023. PMID: 37974180 Free PMC article. Review.
Cited by
-
Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition.J Lipid Res. 2011 Dec;52(12):2262-2271. doi: 10.1194/jlr.M018283. Epub 2011 Sep 21. J Lipid Res. 2011. PMID: 21937674 Free PMC article.
-
Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo.Arterioscler Thromb Vasc Biol. 2009 Jan;29(1):40-6. doi: 10.1161/ATVBAHA.108.177105. Epub 2008 Nov 13. Arterioscler Thromb Vasc Biol. 2009. PMID: 19008531 Free PMC article.
-
Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro.J Lipid Res. 2009 Nov;50(11):2222-34. doi: 10.1194/jlr.M900015-JLR200. Epub 2009 Mar 11. J Lipid Res. 2009. PMID: 19282272 Free PMC article.
-
Identification of a hormone response element that mediates suppression of APOF by LXR and PPARα agonists.Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Mar;1865(3):158583. doi: 10.1016/j.bbalip.2019.158583. Epub 2019 Dec 6. Biochim Biophys Acta Mol Cell Biol Lipids. 2020. PMID: 31812787 Free PMC article.
-
ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters.J Lipid Res. 2019 Nov;60(11):1868-1879. doi: 10.1194/jlr.RA119000171. Epub 2019 Sep 11. J Lipid Res. 2019. PMID: 31511396 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous